Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Thumbnail

AI improves Cochlear implant placement

Auditory specialists placing Cochlear implants in hearing-impaired patients may position the devices better with an assist from AI than with conventional methods. 

Thumbnail

Fujifilm SonoSite brings in Allen Institute’s AI2 Incubator

Portable ultrasound maker Fujifilm SonoSite has turned to the nonprofit Allen Institute for Artificial Intelligence’s AI2 Incubator for help harnessing AI’s image-interpretation potential.

Thumbnail

Novel AI approach shows powerful potential to diagnose Alzheimer’s early, easily

Machine learning analysis of Raman hyperspectroscopy—a technology used to measure the intensity of scattered laser light—has shown strong potential as a screening tool for Alzheimer’s disease when applied to an easily obtainable lab specimen: saliva.

Thumbnail

Medical smartphone apps widely studied for potential but not for actual use

There’s plenty of research into the diagnostic accuracy of medical smartphone apps created to supply clinical decision support (CDS). However, few studies have looked at how helpful these apps are in clinical practice.

Thumbnail

Why Israel is a testing ground for AI in healthcare

Israel is quickly becoming a hotbed for AI in healthcare thanks to new investments to combine digital health records into a giant system that creates true interoperability to maximize use of AI programs and data analytics, The Wall Street Journal reported.

Thumbnail

AI predicts oral cancer survival

The chances of surviving oral cancer can now be predicted from AI algorithms by measuring immune cells in tumors.

Thumbnail

European parliamentarian: ‘Who is liable if an AI-based diagnosis is incorrect?’

Emerging technologies like AI and robotics have vast potential to improve healthcare. Few question this. What remains unclear is how meaningful the advances will be to healthcare providers and, more to the point, the patients they serve.

Thumbnail

Civica Rx pens another deal for drug in short supply

Civica Rx, a not-for-profit drug company with $100 million in funding that aims to combat drug shortages, has inked its next deal with Exela Pharma Sciences to supply its membership of hospitals with sodium bicarbonate injections.